What Dolormin extra Treats: Main Uses and Benefits

The medication is applied across therapeutic domains involving symptomatic discomfort and is commonly used for short-term assistance with pain, fever, and inflammation.

Dolormin extra is generally applied across conditions presenting with acute episodes, helping to manage symptoms that interfere with daily stability. The therapeutic scope is relevant for easing mild to moderate pain episodes, including headache, toothache, and the discomfort associated with menstruation. It is also commonly used to help with distressing systemic symptoms such as elevated body temperature and generalized body aches often associated with cold or flu-like illnesses.

The medication is applied during phases of increased distress or discomfort:

“The medication assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.”

---

Quick Fact: Symptomatic Support

• Symptom Domain: Pain, Fever, and Inflammation
• Targeted Severity: Mild to Moderate Pain
• Patient Benefit: Supports general well-being during symptomatic phases
• Clinical Context: Short-term management of episodic discomfort

Eligibility Profile

This medicine is generally intended for adults and adolescents starting from 12 years of age with a body weight of at least 40 kg. Younger children and those below this weight are typically excluded from using adult formulations. Use in the elderly requires particular caution and professional consultation due to an increased risk of adverse reactions.

---

Contraindicated Populations

Dolormin extra is strictly contraindicated (prohibited) for use in several patient populations, based on official regulatory documentation:

• Individuals with a known hypersensitivity (allergic reaction) to ibuprofen, aspirin, other NSAIDs, or any other component of the medicine.
• Patients with active or a history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes).
• Those with a history of gastrointestinal bleeding or perforation related to previous NSAID use.
• Patients suffering from severe heart failure (e.g., NYHA Class IV), severe renal failure, or severe hepatic failure.
• Individuals with active bleeding (e.g., cerebrovascular haemorrhage) or unclarified blood-formation disturbances.
• Women in the last trimester of pregnancy.

---

Restricted Use

Patients with mild to moderate renal or hepatic impairment are permitted to use the medicine but require careful monitoring and must use the lowest effective dose for the shortest duration necessary.

Interactions with other medicines and products

Official regulatory information for Ibuprofen, the active ingredient in Dolormin extra, documents specific interactions that fall into two primary risk categories: interactions that increase the risk of bleeding or ulceration, and interactions that alter drug concentrations in the body.

Documented Interaction Patterns

Interaction Type	Interacting Substance Categories
Increased Bleeding/Ulceration Risk	Other NSAIDs (including COX-2 inhibitors), Anticoagulants (e.g., Warfarin), Antiplatelet agents, Oral Corticosteroids, and SSRIs.
Altered Drug Clearance	Lithium, Methotrexate, and Cardiac Glycosides (e.g., Digoxin).
Diminished Therapeutic Effect	Antihypertensives (ACE inhibitors, ARBs) and Diuretics.

Co-administration with other NSAIDs should be avoided due to the additive risk of gastrointestinal adverse effects. The medicine may also diminish the antihypertensive effects of co-administered medicines, and combining it with Diuretics may increase the risk of nephrotoxicity in dehydrated patients. Interactions with Lithium and Methotrexate have been shown to increase the plasma levels of these substances by reducing their clearance.

Specific timing requirements exist for co-administration with low-dose Acetylsalicylic Acid (Aspirin) to manage the potential for interference with its antiplatelet effect. Additionally, the risk of stomach bleeding is officially documented to be increased when consuming alcohol while taking this medicine.

The Pharmacodynamic Mechanism

The active molecule, Ibuprofen, exerts its effects by modulating the activity of the Cyclooxygenase (COX) enzyme system in central and peripheral pathways. The primary action is the non-selective, competitive, and reversible inhibition of both COX-1 and COX-2 enzymes. By binding to these targets, the drug halts the conversion of the fatty acid arachidonic acid into prostaglandins, which are key physiological mediators. This action leads directly to a reduction of prostanoid-mediated signaling within inflammatory and nociceptive pathways.

Peripherally, reduced PGE2 attenuates the PGE2-mediated sensitization of nociceptors. Centrally, the drug acts in the hypothalamus to modulate the PGE2-induced shift of the body's thermal set point. The medicine is formulated as the Lysinate salt, a pharmacokinetic enhancement that accelerates the absorption rate of the active molecule, thereby accelerating the rate at which the active molecule inhibits COX enzyme activity and initiates the pharmacodynamic consequences.

How to Use Dolormin extra

The usage of Dolormin extra involves a protocol for its oral administration and dosing limits. The medicine is supplied as a film-coated tablet intended only for oral use, which must be swallowed whole with water. The active ingredient is Ibuprofen, formulated as the highly soluble lysinate salt to promote rapid absorption kinetics.

Official Dosing and Frequency

Administration follows a structured regimen for adults and adolescents aged 12 years and over (or at least 40 kg body weight). The standard single starting dose ranges from 200 mg to 400 mg Ibuprofen. Administration can be repeated, but a mandatory minimum interval of 6 hours must be observed between doses. The total intake should not exceed the Maximum Daily Dose of 1200 mg Ibuprofen within a 24-hour period.

Administration Context and Duration

The fundamental principle guiding the use of this medicine is to apply the lowest effective dose for the shortest duration necessary to achieve the desired effect. Established guidelines define clear time constraints for self-treatment: the medicine should not be used for more than 4 consecutive days for pain or 3 days for fever without medical consultation. For patients with known stomach sensitivity, the medicine is instructed to be taken with or after food. If a dose is missed, the procedure requires continuing the schedule at the next designated time without taking a double dose.

Dolormin extra: Recent Clinical Evidence

---

Evidence for Acute Pain Relief

Research exploring the medicine's active ingredient was evaluated in research exploring outcomes related to physical discomfort, particularly in conditions involving episodic or acute changes. Studies conducted to assess short-term symptom patterns primarily involve randomized, controlled clinical trials (RCTs) where the medicine studies included a placebo or active comparator. Findings describe patterns observed in the studies related to measured changes in pain intensity and the time it took for symptoms to change in the observed populations.

However, when trials specifically compared the rapid-action Ibuprofen lysinate formulation (the active ingredient in Dolormin extra) directly against standard Ibuprofen, research has explored whether this accelerated pace was associated with a statistically significant or faster onset of pain relief in key comparative studies. Therefore, the extent to which the speedier absorption translates to a measurable clinical difference remains an area where certainty remains low across the full body of comparative evidence.

---

Evidence for Fever Reduction (Antipyresis)

The medicine was evaluated in research exploring symptoms related to a temporary physiological imbalance, specifically elevated body temperature or fever. The evidence base includes both comparative clinical trials and systematic literature reviews which examined outcomes such as changes in systemic or functional imbalance. Comparative studies examined temperature change relative to other antipyretic agents. Systematic reviews have highlighted that research reports mixed findings when comparing the active ingredient with other antipyretic agents in certain patient groups.

---

Evidence on the Rapid-Action Formulation

The specific formulation, Ibuprofen lysinate, was the focus of specialized pharmacokinetic studies and randomized crossover trials to examine its absorption properties. Research describes patterns consistent with faster absorption from the digestive system into the bloodstream. The key limitation is that, while studies indicate patterns consistent with faster absorption, whether this translates to a statistically faster onset of pain relief in patients is not fully established across all direct comparative trials.

---

What is Still Uncertain About the Research Landscape

Research provides limited insight into long-term outcomes, as follow-up durations were short in most key trials focusing on acute symptom management. The evidence quality varies across studies, and while the active ingredient is well-studied, comparative evidence remains limited for the specific formulation (Ibuprofen lysinate) against a wide range of other currently available pain relievers. The study results apply to the specific populations enrolled in the main RCTs, and subgroup findings are uncertain.

Common questions about Dolormin extra (FAQ)

---

Q: Does the addition of lysine make Dolormin extra start working faster than regular ibuprofen?

Official product information describes the Ibuprofen lysinate formulation as having rapid absorption kinetics, meaning it is absorbed more quickly by the body. This specific formulation is intended to result in a faster onset of therapeutic effect compared to standard ibuprofen preparations.

---

Q: Does the quick release formulation of Dolormin extra affect its duration of action?

The duration of pain relief for this formulation is described in the official product information. The analgesic effect is described in product information as lasting up to 8 hours.

---

Q: Is the fast action the only difference between Dolormin extra and plain ibuprofen?

The primary difference documented in the product information is the use of the lysine salt. This modification is specifically designed to lead to faster absorption of the active ingredient compared to standard ibuprofen formulations.

---

Q: What is the difference between Dolormin extra and standard ibuprofen brands like Advil or Motrin?

The difference lies in the chemical structure of the active ingredient. Dolormin extra utilizes Ibuprofen lysinate, which is a highly soluble salt, while many standard non-prescription brands often contain Ibuprofen free acid. The lysinate salt is a key differentiation factor intended to be absorbed more quickly.

---

Q: Does taking Dolormin extra increase the risk of stomach issues or heartburn?

Gastrointestinal discomfort is listed among the possible common side effects of the active ingredient. This includes symptoms such as heartburn and nausea.

---

Q: What are the common side effects listed for the combination of ibuprofen and lysine?

According to the official product information, the most frequently observed adverse events are gastrointestinal in nature. These common issues typically include abdominal pain, indigestion, nausea, and diarrhea.

---

Q: What are the signs of a possible allergic reaction to Dolormin extra?

Signs of a hypersensitivity reaction may include the development of rashes, itching, hives (urticaria), or swelling of the face, tongue, or larynx (angioedema). Signs suggesting a severe reaction indicate the need for immediate medical consultation.

---

Q: What are the possible symptoms of taking too much of the active ingredient?

Symptoms of overdose documented in official summaries may include nausea, vomiting, ringing in the ears, headache, and stomach pain. In more serious instances, signs such as decreased level of consciousness or low blood pressure have been reported.

---

Q: Is there a known interaction between Dolormin extra and alcohol consumption?

Yes, official warnings address this combination. Regulatory documentation states that the risk of gastrointestinal bleeding is increased when consuming alcohol while taking this medicine.

---

Q: How long does the pain relief effect of Dolormin extra typically last?

The medicine is a rapid-action formulation. The pain-relieving effect of a single dose is stated in product information to last up to 8 hours.

---

Q: How quickly can a user generally expect Dolormin extra to start working?

The medicine is a rapid-action formulation. The onset of the pain-relieving effect is commonly referenced in product information as starting within 15 minutes of administration.

---

Q: Is Dolormin extra described as appropriate for use during pregnancy in regulatory documents?

Regulatory warnings state that the medicine is strictly contraindicated in the last trimester of pregnancy. Furthermore, its use is generally not recommended in the first and second trimesters unless deemed necessary and supervised by a medical professional due to potential risks.

---

Q: Can people with known heart conditions use Dolormin extra?

Official information states the medicine is contraindicated in cases of severe heart failure. Warnings indicate the medicine may increase the risk of cardiovascular thrombotic events and advise caution for use in patients with existing heart conditions or related risk factors.

---

Q: Can using Dolormin extra regularly lead to a headache condition known as 'medication overuse headache'?

Yes, frequent or prolonged use of the active ingredient (Ibuprofen) is associated with the risk of developing a condition known as medication overuse headache. Official guidance sets limits for self-treatment to no more than four consecutive days for pain or three days for fever.

---

Q: What information is available on the long-term use safety of Dolormin extra?

Regulatory warnings indicate that the risks of serious adverse events may increase with prolonged use of the medication. This includes increased risk of gastrointestinal bleeding and cardiovascular thrombotic events.

---

Q: Is there specific information regarding severe skin reactions when taking this medication?

Official warnings explicitly document the very rare but serious risk of severe skin reactions. These documented conditions include Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS syndrome.

---

Q: Are there specific concerns for patients with asthma taking Dolormin extra?

Patients who have or have had asthma or other hypersensitivity reactions (especially to aspirin) are noted to be at an increased risk. This risk involves experiencing exacerbated asthma, bronchospasm, or a full allergic reaction when taking this medicine.

---

Q: Are there foods or supplements that are known to interact with the drug?

Official documentation lists potential interactions with several categories of prescription medicines, such as anticoagulants and antiplatelet agents. There is no specific official warning regarding common foods or vitamins.

---

Q: Is Dolormin extra the right type of medicine for menstrual pain?

Yes, the medicine is officially indicated for the symptomatic short-term treatment of period pains, also known as primary dysmenorrhea.

---

Q: Does the effect of Dolormin extra change if taken on an empty stomach?

While the medicine is formulated for rapid action, official documentation advises that for patients with known stomach sensitivity, it should be taken with or after food. Taking it with food is associated with potentially reduced absorption rate.

---

Q: Does the medicine contain gluten or any common allergens other than the active ingredients?

The full list of excipients (other ingredients) is available in the official product information, typically in Section 6. Patients should review this list, which includes substances such as magnesium stearate and microcrystalline cellulose, for potential non-active ingredient allergens.

Storage and Disposal of Dolormin extra

Dolormin extra film-coated tablets must be stored according to official regulatory specifications to maintain product quality.

Storage Requirements

Condition	Requirement
Temperature	Store at room temperature, generally not exceeding 30 C.
Protection	Keep the medicine in the original package to protect it from light and moisture.
Handling	Do not refrigerate or freeze the tablets.
Safety	Keep out of the sight and reach of children.

Use of the medicine is prohibited after the expiration date printed on the carton and blister.

Disposal Instructions

Expired or unused Dolormin extra must not be disposed of in regular household waste or flushed down the toilet or sink (wastewater). To ensure environmentally responsible handling, return the product to a pharmacy or official pharmaceutical take-back program.